Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

Implementation of risk-based lipid-lowering therapies in older (age ≥ 65 years) and very-old adults (age ≥ 75 years) with ischemic heart disease in the greater Salzburg region

Introduction: European guidelines recommend the implementation of lipid-lowering therapies (LLTs) in adults (≥ 65 years) with established atherosclerotic cardiovascular disease (ASCVD) and for risk-based primary prevention in older adults (≤ 75 years), yet their use in very-old adults (> 75 y...

Full description

Bibliographic Details
Main Authors: Kristen Kopp, Lukas J. Motloch, Bernhard Wernly, Alexander E. Berezin, Victoria Maringgele, Anna Dieplinger, Uta C. Hoppe, Michael Lichtenauer
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-06-01
Series:Frontiers in Pharmacology
Subjects:
older adults
low-density lipoprotein cholesterol
lipid-lowering therapy
guidelines
ST-segment elevation myocardial infarction
very-high risk
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2024.1357334/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2024.1357334/full

Similar Items